The U.S. Food and Drug Administration has approved a prefilled syringe version of Netherlands-based Argenx SE's blockbuster ...

Exclusive-Pharma Industry Lobbies Trump for Phased Tariffs, Sources Say By Maggie Fick and Michael Erman LONDON/NEW YORK (Reuters) -Drugmakers are lobbying U.S. President Donald Trump to phase in ...

Eye drops are not a standard treatment for age-related macular degeneration (AMD), but some eye drop medications are in development that may become viable options in the future. AMD affects a ...

Soon after President Trump won the presidential election in November, British drugmaker GSK brought an unusual claim to federal prosecutors in Manhattan, according to people familiar with the ...

US President Donald Trump has again singled out Ireland's pharmaceutical industry as a target for tariffs. Trump was speaking as he announced 25% tariffs on cars and car parts imported into the US.

A new study suggests that never-seen-before stem cells in the human retina can restore vision in mice with a common eye disorder. But more work is needed to translate the treatment to people.

The best bronzing drops are fast becoming a holy grail beauty product. Blurring the lines between fake tan and make-up, these supercharged formulas give your face a golden glow without the sun ...

Looking ahead, this article highlights the key trends expected to shape the regulatory landscape of pharmaceutical manufacturing in 2025. Regulatory agencies—including the U.S. Food and Drug ...

Helix is one of the top mattress brands in the US, with a USP of having a mattress to suit every sleeping style and body weight. The Helix Twilight and Helix Midnight are both designed ...

The Standard's journalism is supported by our readers. When you purchase through links on our site, we may earn an affiliate commission. Tired, hot and sore: do these sound like your eyes after a ...

Kennedy Jr.’s plans against the pharmaceutical businesses. Robert F. Kennedy Jr., the nephew of former US President John F. Kennedy, was appointed the Secretary of Health and Human Services in ...

There remains much uncertainty about these measures, however. As ever in the often quick-developing biotech and pharmaceutical sectors on Tuesday, companies posted a mix of positive and negative news.